Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats - Wikidata - awgldk - TriplyDB

Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats

Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats

http://www.wikidata.org/entity/Q28213026

about

sameAs

Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory Neuroinflammatory responses in diabetic retinopathy Primary retinal cultures as a tool for modeling diabetic retinopathy: an overview Reduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications.Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC)Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity.Diabetic retinopathy: current management and experimental therapeutic targets.siah-1 Protein is necessary for high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation and cell death in Muller cells Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function.Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy.Pigment epithelium-derived factor protects the morphological structure of retinal Müller cells in diabetic rats Müller cell reactivity in response to photoreceptor degeneration in rats with defective polycystin-2.Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model.TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy.Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line Progression of Diabetic Capillary Occlusion: A Model.Retinylamine Benefits Early Diabetic Retinopathy in Mice A Computational Model of Peripheral Photocoagulation for the Prevention of Progressive Diabetic Capillary Occlusion PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Targets of tyrosine nitration in diabetic rat retina.Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro.In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine.A review of the role of glial cells in understanding retinal disease.Expression, subcellular localization, and regulation of sigma receptor in retinal muller cells.Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.Normal aging involves modulation of specific inflammatory markers in the rat retina and choroid.Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy.Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells.Anti-inflammatory therapy for diabetic retinopathy.Inflammation in diabetic retinopathy.Topical nonsteroidal anti-inflammatory drugs for macular edema.Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy.

P2860

Q24647760-91CC3FB6-9C41-4415-BD56-BCC42999182D Q26798351-205A6599-2CC2-45FA-AC4B-CDBD274E4616 Q27008921-040C040D-C77E-4DE6-B45E-BF17776A82A9 Q28564310-8940CFE4-9684-43D9-9D1C-61ED04E7D112 Q28579534-B8D37022-E4FB-4241-99D7-2ECEE0711521 Q28580237-2C2FF08E-0CD4-4818-BCA3-A05B6975B105 Q28730878-0478CDD3-08FD-4BD8-9787-71FDA4E6B3AF Q31083347-90836F5F-0665-4DCA-BBF6-9948BA67D583 Q33403016-52577CFA-1CCC-44F7-AB3E-CEAD5DB743D6 Q33661741-B89884AC-A067-4FE8-94A6-5B8B7039DF46 Q33845105-33883DFB-9E62-41D1-B8FB-F61B1D002679 Q34718901-61B0E3F2-CBAE-40E4-875D-41EDCF278B57 Q34735773-D7C2837C-7BC1-4919-8F3F-E45FF42F3153 Q34765503-DD48B0B1-7C88-4FFC-9AFA-06D57EB1F86A Q35020672-E40DB937-FBDA-495C-9147-E78B60256A97 Q35168171-22547860-FE2A-496C-A6D1-1DA699DC4D5B Q35855616-875B809F-B84A-4F6A-8E7B-85ABC1AD3AFA Q35885116-F850BF05-7FEC-4990-9D1F-9B48582F165F Q36032332-415A6C6D-0521-4185-9D3D-F239E75A4BC4 Q36051940-67ED757D-7D66-436E-BD36-96EF2F3C64EF Q36065113-4DD28199-8568-4B96-B0D4-3FC485EAA10A Q36193639-583A14A5-54FC-400E-A921-29B6DBDF9E93 Q36624751-E31EA3E6-285A-4400-8671-F2320592D062 Q36685034-24819558-B88D-4342-BF67-1CA401A22867 Q36756478-1FA276A9-B740-4DA9-B4C3-8124FF1D06FA Q36890895-ED3351D6-EB3C-4583-B55C-177863283333 Q36925899-C57F546D-1930-48A7-A1FD-FFC7A6AC3540 Q37018128-F09C3DB7-519F-4AFA-AAA8-94F2930AE3C9 Q37047868-9EB04843-F6B9-4501-A1A1-B1D13DC00421 Q37084522-BE22A8FA-5CCF-465D-8D84-2D40239A9DFA Q37106691-666B894D-1934-4FCB-AB21-ED64E3B866D6 Q37126586-B1B241DF-FAAC-4ABE-876A-F22193F7830E Q37418982-18C9A0C3-FBB7-4147-B0CC-0F5EB763D110 Q37526773-3D1B20ED-EC90-41A7-B990-89E3283C02CC Q37873482-E237550C-7285-4B9C-B804-3EEE07A41E03 Q37884176-8C3B4BC5-81B6-4948-8722-20F4812D89E6 Q38162433-D5B3FB32-2E45-4C1F-96EC-36BF77592AF2 Q38656281-282C042B-05B9-4CA4-9CE1-8B6CC03AE8F3 Q38873909-D764DADC-F561-48B5-8FA0-7FA5BDB4BBB6 Q38914306-67FD6504-E10F-443F-9CC5-926C551398C5

P2860

Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats

http://www.wikidata.org/entity/Q28213026

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Interaction between NO and COX ...... se and retina of diabetic rats

@ast

Interaction between NO and COX ...... se and retina of diabetic rats

@en

Interaction between NO and COX ...... se and retina of diabetic rats

@nl

type

label

Interaction between NO and COX ...... se and retina of diabetic rats

@ast

Interaction between NO and COX ...... se and retina of diabetic rats

@en

Interaction between NO and COX ...... se and retina of diabetic rats

@nl

prefLabel

Interaction between NO and COX ...... se and retina of diabetic rats

@ast

Interaction between NO and COX ...... se and retina of diabetic rats

@en

Interaction between NO and COX ...... se and retina of diabetic rats

@nl

P1433

Q28213026-C8844F85-F705-4DE2-BF19-76FED2564837

P1476

Q28213026-08EE84DA-940A-4443-96E6-8481BDAC561D

P2093

Q28213026-7EDD3B96-54D4-4851-B3DB-7DEE5676CBFF

Q28213026-867BBCC8-218B-48AC-B903-310105EC3639

Q28213026-D0D8B04B-BDA6-4DE0-8A61-C370FF5EFC17

P2860

Q28213026-012EA1CB-74F9-4D09-AE77-8672F54E00F1

Q28213026-10F0C7C4-60D0-4165-AC7F-109BED2E687C

Q28213026-164D0B5E-4B01-46BB-9FA9-3F4550564B9A

Q28213026-276F85E5-21AE-4EB9-873C-C6DEA1D5FD32

Q28213026-4279D4AE-8BCD-4153-8D3B-4BA49CC4F71B

Q28213026-43B6DEA2-D20E-4430-9CDF-98F1DAA252A4

Q28213026-4CEC8CF4-1D0E-4D42-8B79-9145DF7FA237

Q28213026-5182FE7D-2766-4E97-B418-2582C60B5653

Q28213026-6A6D63BD-7D64-4592-819B-C6DE9906FF3B

Q28213026-6EDCB8F1-3C1A-4ECB-86E6-DBC2316CAF8E

P304

Q28213026-D3148567-0D89-42B4-BC4E-14C0EE378A0A

P31

Q28213026-7979EDCB-E136-4B84-8F53-41D900AB3B4F

P3181

Q28213026-F7D5E84D-A043-4C7F-8013-AC8FFAC17832

P356

Q28213026-B771A529-F57A-4D9B-9A4E-2E352A756CDC

P407

Q28213026-0FB837ED-4A60-4245-938F-E14E4E553A0E

P433

Q28213026-7F1FB6F3-0B11-4186-BFEC-23B9661E3153

P478

Q28213026-D8B27DE3-8225-44B0-B79E-3052F3FEF5B6

P577

Q28213026-586C462D-84A6-45A6-883C-65A8E767CF8F

P5875

Q28213026-6BD63B58-37AD-4C35-8688-45EAF467306F

P698

Q28213026-DD87B99C-D8D6-4A36-A9CA-1647C30BBA9F

P921

Q28213026-d3436c72-1aab-4e0d-b17f-4c24caa731e0

P3181

P356

AJPREGU.00080.2003

P1433

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

P1476

Interaction between NO and COX ...... se and retina of diabetic rats

@en

P2093

T S Kern

http://www.w3.org/2001/XMLSchema#string

V P Sarthy

http://www.w3.org/2001/XMLSchema#string

Yunpeng Du

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

Inhibition of NF-kappa B by sodium salicylate and aspirin

Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug.

Interactions between the inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) pathways: implications for therapeutic intervention in osteoarthritis.

Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy.

Nitric oxide activates cyclooxygenase enzymes.

Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis.

Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

Purification and characterization of the constitutive nitric oxide synthase from human placenta.

P304

R735-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

823297

http://www.w3.org/2001/XMLSchema#string

P356

10.1152/AJPREGU.00080.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8344106

http://www.w3.org/2001/XMLSchema#string

P698

15371279

http://www.w3.org/2001/XMLSchema#string

P921